Skip to main content
Clinical Trials/NCT05474014
NCT05474014
Completed
Not Applicable

Investigation of the Effectiveness of Superior Trunk Block Applied for Upper Arm Surgery Operation Analgesia

Bursa Yüksek İhtisas Education and Research Hospital1 site in 1 country60 target enrollmentJuly 20, 2022

Overview

Phase
Not Applicable
Intervention
superior trunk block
Conditions
Post Operative Pain
Sponsor
Bursa Yüksek İhtisas Education and Research Hospital
Enrollment
60
Locations
1
Primary Endpoint
Visual Analog Scale
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

Nerve blocks applied with ultrasonography are currently used for many post-operative pain and operations. Providing adequate area analgesia is the primary goal of clinicians, as early mobilization is suggested after shoulder and arm surgery.

In this study aimed to investigate the effect of superior trunk block application on postoperative analgesic and motor functions.

Registry
clinicaltrials.gov
Start Date
July 20, 2022
End Date
December 1, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Bursa Yüksek İhtisas Education and Research Hospital
Responsible Party
Principal Investigator
Principal Investigator

Korgün Ökmen

Assoc.Phd.M.D

Bursa Yüksek İhtisas Education and Research Hospital

Eligibility Criteria

Inclusion Criteria

  • Patients who were in the American Society of Anesthesiologists (ASA) I-III class
  • Underwent upper arm surgery

Exclusion Criteria

  • Previous local anesthetic allergy,
  • Having a bleeding diathesis disorder,
  • Mental disorder,
  • Allergic to the drugs used,
  • Patients who did not consent to participate in the study,
  • Presence of infection in the block area,
  • Patients with a body mass index above 30

Arms & Interventions

superior trunk block

Ultrasound guided superior trunk block with 10 ml % 0.25 bupivacaine + 400 mg tramadol, IV 4 mg/ mL tramadol solution into 100 mL normal saline; PCA (patient-controlled analgesia): 0.3 mg/kg bolus, 10 mg Demand dose and 20 min lock out interval, six-hour limit infusion to attain 100 mg. Maximum daily dose was set at 400 mg.

Intervention: superior trunk block

superior trunk block

Ultrasound guided superior trunk block with 10 ml % 0.25 bupivacaine + 400 mg tramadol, IV 4 mg/ mL tramadol solution into 100 mL normal saline; PCA (patient-controlled analgesia): 0.3 mg/kg bolus, 10 mg Demand dose and 20 min lock out interval, six-hour limit infusion to attain 100 mg. Maximum daily dose was set at 400 mg.

Intervention: intravenous patient-controlled analgesia

tramadol

400 mg tramadol, IV 4 mg/ mL tramadol solution into 100 mL normal saline; PCA (patient-controlled analgesia): 0.3 mg/kg bolus, 10 mg Demand dose and 20 min lock out interval, six-hour limit infusion to attain 100 mg. Maximum daily dose was set at 400 mg.

Intervention: intravenous patient-controlled analgesia

Outcomes

Primary Outcomes

Visual Analog Scale

Time Frame: Postoperative 24 hours

Visual Analog Scale was used for pain.Pain intensity was measured using 0-10 cm visual analogue scale (VAS). (0=no pain, 10=intolerable pain)

Secondary Outcomes

  • additional analgesic use amount(Postoperative 24 hours)
  • postoperative complications(Postoperative 24 hours)
  • Horner syndrome(Postoperative 24 hours)
  • tramadol consumption amount(Postoperative 24 hours)

Study Sites (1)

Loading locations...

Similar Trials